Portage Biotech Inc (PRTG) shares were soaring more than 212% in Tuesday's premarket activity after the clinical-stage immuno-oncology company said Tuesday it has entered into a letter of intent with biotech firm Immunova.
Financial terms weren't disclosed.
Under terms of the proposed deal, Portage and Immunova will negotiate a definitive option agreement for Immunova, or an affiliate, to acquire the entire share capital of Portage subsidiary iOx Therapeutics.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments